Compare HLN & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | FANG |
|---|---|---|
| Founded | 2022 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Oil & Gas Production |
| Sector | Consumer Discretionary | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7B | 51.4B |
| IPO Year | N/A | 2012 |
| Metric | HLN | FANG |
|---|---|---|
| Price | $10.07 | $192.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 20 |
| Target Price | N/A | ★ $197.28 |
| AVG Volume (30 Days) | ★ 8.3M | 3.3M |
| Earning Date | 02-26-2026 | 05-04-2026 |
| Dividend Yield | 1.77% | ★ 2.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.73 |
| Revenue | N/A | ★ $15,026,000,000.00 |
| Revenue This Year | $7.04 | N/A |
| Revenue Next Year | $4.58 | $8.29 |
| P/E Ratio | $49.05 | ★ $33.21 |
| Revenue Growth | N/A | ★ 35.79 |
| 52 Week Low | $8.71 | $114.00 |
| 52 Week High | $11.42 | $193.75 |
| Indicator | HLN | FANG |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 71.29 |
| Support Level | $9.98 | $136.41 |
| Resistance Level | $10.31 | N/A |
| Average True Range (ATR) | 0.15 | 5.66 |
| MACD | -0.03 | 0.93 |
| Stochastic Oscillator | 14.30 | 89.16 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.